128 related articles for article (PubMed ID: 27304653)
41. Anterior placenta previa is associated with increased umbilical cord blood hematocrit concenrations.
Daglar K; Tokmak A; Kirbas A; Kara O; Biberoglu E; Uygur D; Danisman N
J Neonatal Perinatal Med; 2016 Sep; 9(3):279-84. PubMed ID: 27589555
[TBL] [Abstract][Full Text] [Related]
42. [Placenta previa accreta].
Cieminski A; Długołiecki F
Ginekol Pol; 2004 Dec; 75(12):919-25. PubMed ID: 15751211
[TBL] [Abstract][Full Text] [Related]
43. Delta Neutrophil Index as a Promising Biomarker for Placental Implantation Disorders.
Karakoç G; Yalcin SE; Yavuz A; Sarsmaz K; Şengül M; Yucel A
Z Geburtshilfe Neonatol; 2021 Oct; 225(5):412-417. PubMed ID: 34256391
[TBL] [Abstract][Full Text] [Related]
44. Frequency, Risk Factors, and Adverse Fetomaternal Outcomes of Placenta Previa in Northern Tanzania.
Senkoro EE; Mwanamsangu AH; Chuwa FS; Msuya SE; Mnali OP; Brown BG; Mahande MJ
J Pregnancy; 2017; 2017():5936309. PubMed ID: 28321338
[No Abstract] [Full Text] [Related]
45. A multidisciplinary approach to surgical management of placenta previa percreta with bladder invasion: a case report.
Aguirre D; Caiseda D; Correa-Rivas M; Maldonado M; Rodríguez W; Miranda G; Lugo A; Gandia J
P R Health Sci J; 2006 Jun; 25(2):163-5. PubMed ID: 17203716
[TBL] [Abstract][Full Text] [Related]
46. Placental mRNA in maternal plasma and its clinical application to the evaluation of placental status in a pregnant woman with placenta previa-percreta.
Masuzaki H; Miura K; Yoshiura K; Yamasaki K; Miura S; Yoshimura S; Nakayama D; Mapendano CK; Niikawa N; Ishimaru T
Clin Chem; 2005 May; 51(5):923-5. PubMed ID: 15855676
[No Abstract] [Full Text] [Related]
47. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound.
Chou MM; Ho ES; Lee YH
Ultrasound Obstet Gynecol; 2000 Jan; 15(1):28-35. PubMed ID: 10776009
[TBL] [Abstract][Full Text] [Related]
48. The value of specific MRI features in the evaluation of suspected placental invasion.
Lax A; Prince MR; Mennitt KW; Schwebach JR; Budorick NE
Magn Reson Imaging; 2007 Jan; 25(1):87-93. PubMed ID: 17222719
[TBL] [Abstract][Full Text] [Related]
49. Serum angiogenic profile in abnormal placentation.
Biberoglu E; Kirbas A; Daglar K; Biberoglu K; Timur H; Demirtas C; Karabulut E; Danisman N
J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3193-7. PubMed ID: 26863111
[TBL] [Abstract][Full Text] [Related]
50. Society for Maternal-Fetal Medicine (SMFM) Consult Series #44: Management of bleeding in the late preterm period.
; Gyamfi-Bannerman C
Am J Obstet Gynecol; 2018 Jan; 218(1):B2-B8. PubMed ID: 29079144
[TBL] [Abstract][Full Text] [Related]
51. Increased level of cell-free placental mRNA in a subgroup of placenta previa that needs hysterectomy.
Miura K; Miura S; Yamasaki K; Yoshida A; Yoshiura K; Nakayama D; Niikawa N; Masuzaki H
Prenat Diagn; 2008 Sep; 28(9):805-9. PubMed ID: 18646248
[TBL] [Abstract][Full Text] [Related]
52. [Uterine rupture after twenty-two weeks of amenorrhea due to placenta praevia percreta. A case report].
Mathieu E; Dufour P; Ernoult P; Prolongeau JF; Vinatier D; Ducloy JC; Tordjeman N; Martin de Lasalle E; Monnier JC
Rev Fr Gynecol Obstet; 1995; 90(4):228-32. PubMed ID: 7644872
[TBL] [Abstract][Full Text] [Related]
53. Early placenta previa and delivery outcome.
Comeau J; Shaw L; Marcell CC; Lavery JP
Obstet Gynecol; 1983 May; 61(5):577-80. PubMed ID: 6601250
[TBL] [Abstract][Full Text] [Related]
54. Risk factors and morbidity in patients with placenta previa accreta compared to placenta previa non-accreta.
Zaki ZM; Bahar AM; Ali ME; Albar HA; Gerais MA
Acta Obstet Gynecol Scand; 1998 Apr; 77(4):391-4. PubMed ID: 9598946
[TBL] [Abstract][Full Text] [Related]
55. [Clinical analysis of 47 cases of placenta accreta in the second and third trimesters].
Zhang C; Liu XY; Fan GS; Yang JQ; Liu JT; Bian XM
Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):506-9. PubMed ID: 19080513
[TBL] [Abstract][Full Text] [Related]
56. Second- and third-trimester therapeutic terminations of pregnancy in cases with complete placenta previa--does feticide decrease postdelivery maternal hemorrhage?
Ruano R; Dumez Y; Cabrol D; Dommergues M
Fetal Diagn Ther; 2004; 19(6):475-8. PubMed ID: 15539869
[TBL] [Abstract][Full Text] [Related]
57. Obstetric risk factors associated with placenta previa development: case-control study.
Tuzović L; Djelmis J; Ilijić M
Croat Med J; 2003 Dec; 44(6):728-33. PubMed ID: 14652887
[TBL] [Abstract][Full Text] [Related]
58. Maternal deaths in Japan due to abnormally invasive placenta.
Hasegawa J; Tanaka H; Katsuragi S; Sekizawa A; Ishiwata I; Ikeda T;
Int J Gynaecol Obstet; 2018 Mar; 140(3):375-376. PubMed ID: 29080305
[No Abstract] [Full Text] [Related]
59. Maternal serum markers, characteristics and morbidly adherent placenta in women with previa.
Lyell DJ; Faucett AM; Baer RJ; Blumenfeld YJ; Druzin ML; El-Sayed YY; Shaw GM; Currier RJ; Jelliffe-Pawlowski LL
J Perinatol; 2015 Aug; 35(8):570-4. PubMed ID: 25927270
[TBL] [Abstract][Full Text] [Related]
60. Placenta previa accreta with cervical involvement causing tenacious postpartum hemorrhage: a case report.
Wang PH; Chao HT; Yuan CC; Linn JJ; Yen MS
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Feb; 61(2):116-20. PubMed ID: 9532875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
